Ester Aso

4.0k total citations
66 papers, 3.0k citations indexed

About

Ester Aso is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Physiology. According to data from OpenAlex, Ester Aso has authored 66 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cellular and Molecular Neuroscience, 27 papers in Pharmacology and 25 papers in Physiology. Recurrent topics in Ester Aso's work include Neuroscience and Neuropharmacology Research (27 papers), Cannabis and Cannabinoid Research (21 papers) and Alzheimer's disease research and treatments (20 papers). Ester Aso is often cited by papers focused on Neuroscience and Neuropharmacology Research (27 papers), Cannabis and Cannabinoid Research (21 papers) and Alzheimer's disease research and treatments (20 papers). Ester Aso collaborates with scholars based in Spain, United States and France. Ester Aso's co-authors include Isidró Ferrer, Rafaël Maldonado, Graciela N. Balerio, Margarita Carmona, Pol Andrés‐Benito, Olga Valverde, Andrés Ozaita, Catherine Ledent, Ángel Pazos and Irene López‐González and has published in prestigious journals such as Brain, Scientific Reports and Neuroscience.

In The Last Decade

Ester Aso

65 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ester Aso Spain 33 1.3k 1.2k 940 873 361 66 3.0k
Gian Marco Leggio Italy 36 609 0.5× 868 0.7× 1.2k 1.3× 565 0.6× 346 1.0× 91 3.4k
Francisco Molina‐Holgado United Kingdom 33 1.9k 1.5× 1.2k 1.1× 487 0.5× 380 0.4× 440 1.2× 47 3.3k
Ottavio V. Vitolo United States 20 681 0.5× 1.0k 0.9× 1.2k 1.3× 1.2k 1.4× 383 1.1× 26 3.3k
Alberta Leon Italy 26 826 0.6× 1.2k 1.1× 1.2k 1.2× 699 0.8× 306 0.8× 66 3.2k
Sungho Maeng South Korea 24 1.0k 0.8× 1.1k 0.9× 567 0.6× 311 0.4× 235 0.7× 54 2.7k
Valentina Echeverrı́a United States 36 531 0.4× 705 0.6× 1.3k 1.4× 859 1.0× 519 1.4× 87 3.2k
Marı́a L. de Ceballos Spain 33 2.0k 1.5× 2.0k 1.7× 1.6k 1.7× 996 1.1× 682 1.9× 88 5.0k
Agostino Palmeri Italy 30 994 0.8× 1.1k 0.9× 1.4k 1.5× 2.0k 2.3× 694 1.9× 66 3.6k
Simona Capsoni Italy 39 677 0.5× 1.9k 1.6× 1.3k 1.4× 1.6k 1.8× 596 1.7× 97 4.1k
Carlos A. Saura Spain 34 720 0.6× 1.6k 1.4× 1.9k 2.0× 1.8k 2.0× 544 1.5× 69 4.2k

Countries citing papers authored by Ester Aso

Since Specialization
Citations

This map shows the geographic impact of Ester Aso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Aso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Aso more than expected).

Fields of papers citing papers by Ester Aso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ester Aso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Aso. The network helps show where Ester Aso may publish in the future.

Co-authorship network of co-authors of Ester Aso

This figure shows the co-authorship network connecting the top 25 collaborators of Ester Aso. A scholar is included among the top collaborators of Ester Aso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ester Aso. Ester Aso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castañé, Anna, Albert Adell, Leticia Campa, et al.. (2024). A combination of Δ9-tetrahydrocannabinol and cannabidiol modulates glutamate dynamics in the hippocampus of an animal model of Alzheimer's disease. Neurotherapeutics. 21(5). e00439–e00439. 2 indexed citations
2.
López‐Cano, Marc, Víctor Fernández‐Dueñas, Ana B. Muñoz‐Manchado, et al.. (2024). GPR37 processing in neurodegeneration: a potential marker for Parkinson’s Disease progression rate. npj Parkinson s Disease. 10(1). 172–172. 4 indexed citations
3.
Aguado, Carolina, Ákos Kulik, Luis de la Ossa, et al.. (2024). Nanoarchitecture of CaV2.1 channels and GABAB receptors in the mouse hippocampus: Impact of APP/PS1 pathology. Brain Pathology. 35(2). e13279–e13279. 2 indexed citations
4.
Chevigné, Andy, et al.. (2023). Cannabidiol negatively modulates adenosine A2A receptor functioning in living cells. Acta Neuropsychiatrica. 36(5). 320–324. 3 indexed citations
5.
Folgar, Manuel Isorna, et al.. (2022). Impacto de la legalización del consumo recreativo del cannabis. Adicciones. 35(3). 349–376. 6 indexed citations
6.
Aguado, Carolina, Luis de la Ossa, Ester Aso, et al.. (2022). Nanoscale alterations in GABAB receptors and GIRK channel organization on the hippocampus of APP/PS1 mice. Alzheimer s Research & Therapy. 14(1). 136–136. 16 indexed citations
7.
Callado, Luís F., Ester Aso, Kristoffer Sahlholm, et al.. (2020). Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia. Neuropsychopharmacology. 46(3). 665–672. 30 indexed citations
8.
Aso, Ester, Pol Andrés‐Benito, Laura Caltana, et al.. (2019). Cannabidiol-Enriched Extract Reduced the Cognitive Impairment but Not the Epileptic Seizures in a Lafora Disease Animal Model. Cannabis and Cannabinoid Research. 5(2). 150–163. 11 indexed citations
9.
Aso, Ester, Víctor Fernández‐Dueñas, Marc López‐Cano, et al.. (2019). Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ9-Tetrahydrocannabinol-Induced Cognitive Impairment. Molecular Neurobiology. 56(8). 5382–5391. 43 indexed citations
10.
Silva-Abreu, Marcelle, Ana Cristina Calpena, Pol Andrés‐Benito, et al.. (2018). PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer’s disease: in vitro and in vivo studies. International Journal of Nanomedicine. Volume 13. 5577–5590. 64 indexed citations
11.
López‐González, Irene, Agatha Schlüter, Ester Aso, et al.. (2015). Neuroinflammatory Signals in Alzheimer Disease and APP/PS1 Transgenic Mice. Journal of Neuropathology & Experimental Neurology. 74(4). 319–344. 105 indexed citations
12.
Robledo, Patricia, Elena Martín‐García, Ester Aso, & Rafaël Maldonado. (2014). Genetically Modified Mice as Tools to Understand the Neurobiological Substrates of Depression. Current Pharmaceutical Design. 20(23). 3718–3737. 3 indexed citations
13.
Aso, Ester, et al.. (2014). Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations. Psychopharmacology. 231(15). 3031–3040. 24 indexed citations
14.
Sánchez‐Mut, José V., Ester Aso, Nicolas Panayotis, et al.. (2013). DNA methylation map of mouse and human brain identifies target genes in Alzheimer’s disease. Brain. 136(10). 3018–3027. 113 indexed citations
15.
Aso, Ester, et al.. (2013). CB 2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice. Journal of Alzheimer s Disease. 35(4). 847–858. 165 indexed citations
16.
Aso, Ester, M. Carmen Valero, Pierre Dubus, et al.. (2010). Essential role of the N-terminal region of TFII-I in viability and behavior. BMC Medical Genetics. 11(1). 61–61. 29 indexed citations
17.
Aso, Ester, Andrés Ozaita, Miquel Àngel Serra, & Rafaël Maldonado. (2010). Genes differentially expressed in CB1 knockout mice: Involvement in the depressive-like phenotype. European Neuropsychopharmacology. 21(1). 11–22. 38 indexed citations
18.
Hoyle, David C., Gabriella Juhász, Ester Aso, et al.. (2010). Shared changes in gene expression in frontal cortex of four genetically modified mouse models of depression. European Neuropsychopharmacology. 21(1). 3–10. 13 indexed citations
19.
Aso, Ester, Andrés Ozaita, Elsa M. Valdizán, et al.. (2007). BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. Journal of Neurochemistry. 105(2). 565–572. 155 indexed citations
20.
Balerio, Graciela N., Ester Aso, & Rafaël Maldonado. (2006). Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology. 184(3-4). 504–513. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gian Marco Leggio Breakdown of academic impact, for papers by Francisco Molina‐Holgado Breakdown of academic impact, for papers by Ottavio V. Vitolo Breakdown of academic impact, for papers by Alberta Leon Breakdown of academic impact, for papers by Sungho Maeng Breakdown of academic impact, for papers by Valentina Echeverrı́a Breakdown of academic impact, for papers by Marı́a L. de Ceballos Breakdown of academic impact, for papers by Agostino Palmeri Breakdown of academic impact, for papers by Simona Capsoni Breakdown of academic impact, for papers by Carlos A. Saura
Rankless by CCL
2026